LFCR
Price
$6.13
Change
+$0.14 (+2.34%)
Updated
Nov 5, 04:00 PM (EDT)
58 days until earnings call
PRPH
Price
$2.08
Change
-$0.11 (-5.02%)
Updated
Nov 5, 04:00 PM (EDT)
2 days until earnings call
Ad is loading...

LFCR vs PRPH

Header iconLFCR vs PRPH Comparison
Open Charts LFCR vs PRPHBanner chart's image
Lifecore Biomedical
Price$6.13
Change+$0.14 (+2.34%)
Volume$10.83K
CapitalizationN/A
ProPhase Labs
Price$2.08
Change-$0.11 (-5.02%)
Volume$8.08K
CapitalizationN/A
View a ticker or compare two or three
LFCR vs PRPH Comparison Chart
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
LFCR vs. PRPH commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Buy and PRPH is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (LFCR: $5.98 vs. PRPH: $2.19)
Brand notoriety: LFCR and PRPH are both not notable
LFCR represents the Pharmaceuticals: Other, while PRPH is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LFCR: 49% vs. PRPH: 146%
Market capitalization -- LFCR: $176.87M vs. PRPH: $116.75M
LFCR [@Pharmaceuticals: Other] is valued at $176.87M. PRPH’s [@Medical Specialties] market capitalization is $116.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.42B. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whilePRPH’s FA Score has 1 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • PRPH’s FA Score: 1 green, 4 red.
According to our system of comparison, LFCR is a better buy in the long-term than PRPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 5 TA indicator(s) are bullish while PRPH’s TA Score has 4 bullish TA indicator(s).

  • LFCR’s TA Score: 5 bullish, 4 bearish.
  • PRPH’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both LFCR and PRPH are a good buy in the short-term.

Price Growth

LFCR (@Pharmaceuticals: Other) experienced а +6.41% price change this week, while PRPH (@Medical Specialties) price change was -8.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was +0.77%, and the average quarterly price growth was -2.42%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.55%. For the same industry, the average monthly price growth was -0.26%, and the average quarterly price growth was -1.49%.

Reported Earning Dates

LFCR is expected to report earnings on Jan 02, 2025.

PRPH is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.55% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LFCR($177M) has a higher market cap than PRPH($117M). LFCR YTD gains are higher at: -3.393 vs. PRPH (-51.549). PRPH has higher annual earnings (EBITDA): -9.64M vs. LFCR (-22.64M). LFCR has more cash in the bank: 4.22M vs. PRPH (3.27M). PRPH has less debt than LFCR: PRPH (18.9M) vs LFCR (157M). LFCR has higher revenues than PRPH: LFCR (188M) vs PRPH (62.7M).
LFCRPRPHLFCR / PRPH
Capitalization177M117M151%
EBITDA-22.64M-9.64M235%
Gain YTD-3.393-51.5497%
P/E RatioN/A17.01-
Revenue188M62.7M300%
Total Cash4.22M3.27M129%
Total Debt157M18.9M831%
FUNDAMENTALS RATINGS
LFCR vs PRPH: Fundamental Ratings
LFCR
PRPH
OUTLOOK RATING
1..100
1717
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
4991
P/E GROWTH RATING
1..100
819
SEASONALITY SCORE
1..100
n/a45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRPH's Valuation (77) in the Household Or Personal Care industry is in the same range as LFCR (91) in the Industrial Specialties industry. This means that PRPH’s stock grew similarly to LFCR’s over the last 12 months.

PRPH's Profit vs Risk Rating (91) in the Household Or Personal Care industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that PRPH’s stock grew similarly to LFCR’s over the last 12 months.

PRPH's SMR Rating (97) in the Household Or Personal Care industry is in the same range as LFCR (97) in the Industrial Specialties industry. This means that PRPH’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (49) in the Industrial Specialties industry is somewhat better than the same rating for PRPH (91) in the Household Or Personal Care industry. This means that LFCR’s stock grew somewhat faster than PRPH’s over the last 12 months.

LFCR's P/E Growth Rating (8) in the Industrial Specialties industry is in the same range as PRPH (19) in the Household Or Personal Care industry. This means that LFCR’s stock grew similarly to PRPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRPRPH
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 27 days ago
77%
Bearish Trend 22 days ago
80%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLPBY12.840.14
+1.10%
Coloplast AS
YARIY15.120.12
+0.80%
Yara International ASA
AIQUY35.76-0.11
-0.31%
L'Air Liquide SA
BRPHF11.65-0.52
-4.23%
Galaxy Digital Holdings Ltd.
HGTXU0.47-0.04
-8.17%
Hugoton Royalty Trust

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+1.79%
SHPH - LFCR
31%
Poorly correlated
-2.99%
CRON - LFCR
29%
Poorly correlated
+1.85%
CGC - LFCR
28%
Poorly correlated
+13.17%
TLRY - LFCR
27%
Poorly correlated
+5.49%
OGI - LFCR
26%
Poorly correlated
+4.05%
More

PRPH and

Correlation & Price change

A.I.dvisor tells us that PRPH and ANIP have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPH and ANIP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRPH
1D Price
Change %
PRPH100%
+2.34%
ANIP - PRPH
28%
Poorly correlated
-3.73%
RXST - PRPH
23%
Poorly correlated
+0.29%
LFCR - PRPH
21%
Poorly correlated
+1.79%
ATRC - PRPH
21%
Poorly correlated
+0.46%
ASRT - PRPH
21%
Poorly correlated
+2.91%
More